Search results
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters via Yahoo Finance Canada· 2 months agoBERLIN (Reuters) -Morphosys said its takeover by Novartis is still expected to close in the first...
MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year
Simply Wall St. via Yahoo Finance Canada· 2 months agoWhen you buy shares in a company, there is always a risk that the price drops to zero. But if you...
MorphoSys Full Year 2022 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance Canada· 1 year agoMorphoSys (ETR:MOR) Full Year 2022 Results Key Financial Results Revenue: €278.3m (up 55% from FY...
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and...
Zacks via Yahoo Finance Canada· 4 months agoFor Immediate Release Chicago, IL – March 11, 2024 – Zacks.com announces the list of stocks featured...
Novartis begins tender offer for cancer-focused MorphoSys
Reuters via Yahoo Canada News· 3 months agoBERLIN (Reuters) -Novartis said on Thursday it has launched a tender offer to acquire MorphoSys, a...
MorphoSys AG (NASDAQ:MOR) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 8 months agoMorphoSys AG (NASDAQ:MOR) Q3 2023 Earnings Call Transcript November 16, 2023 Operator: Ladies and...
MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study
Zacks via Yahoo Finance Canada· 1 year agoAs MorphoSys (MOR) completes enrolment before schedule in a late-stage study evaluating therapy in...
MorphoSys (MOR) Down 22% on Mixed Data From Myelofibrosis Study
Zacks via Yahoo Finance Canada· 7 months agoThough data from the late study shows that treatment with MorphoSys' (MOR) combination therapy met...
Novartis to acquire cancer-focused MorphoSys for $2.9 billion
Reuters via Yahoo Finance Canada· 5 months agoReuters first reported on Monday that Switzerland-based Novartis was in advanced talks to acquire...
Exclusive-Novartis in the lead to acquire cancer drug developer MorphoSys-sources
Reuters via Yahoo Canada News· 5 months ago(Reuters) -Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of...